Ruoyi Jiang's winning project

advertisement | advertise on newsday

Project title: Targeting Loop Dynamics in Beta I / Beta III Isotype Tubulin: The Application of In Silico Techniques in Combating Chemotherapy Drug Resistance

advertisement | advertise on newsday

Description: For his project, Ruoyi Jiang obtained a federal permit to use a government-owned supercomputer in

simulating the effects of the drug Taxol on cancerous tumors. Results allowed Jiang to predict long-range effects of drug binding on protein structure. Results also suggest that such simulations could contribute to development of new drugs for treatment of cancers resistant to older pharmaceuticals.

The best of Newsday every day in your inbox. Get the Newsday Now newsletter!

Comments now uses Facebook for our comment boards. Please read our guidelines and connect your Facebook account to comment.

You also may be interested in: